Inventor
FOSTER KEITH
GB30 patents
⚠️ This page may combine multiple inventors who share the name “FOSTER KEITH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
FOSTER KEITH
11 patentsUS8067200B2Nov 29, 2011
Fusion proteins
FOSTER KEITH43 citations97
US8187834B2May 29, 2012
Non-cytotoxic protein conjugates
FOSTER KEITH33 citations96
US8603779B2Dec 10, 2013
Non-cytotoxic protein conjugates
FOSTER KEITH23 citations92
US8512984B2Aug 20, 2013
Non-cytotoxic protein conjugates
FOSTER KEITH19 citations92
US8399401B2Mar 19, 2013
Fusion proteins
FOSTER KEITH18 citations92
US9243301B2Jan 26, 2016
Fusion proteins
FOSTER KEITH15 citations84
US9139635B2Sep 22, 2015
Non-cytotoxic protein conjugates
FOSTER KEITH4 citations84
US9072736B2Jul 7, 2015
Treatment of pain
FOSTER KEITH8 citations84
US8778634B2Jul 15, 2014
Non-cytotoxic protein conjugates
FOSTER KEITH11 citations84
US8399400B2Mar 19, 2013
Fusion proteins
FOSTER KEITH13 citations84
USD307730SMay 8, 1990
Interchangeable belt attachment
FOSTER KEITH13 citations73
IPSEN BIOINNOVATION LTD
5 patentsUS10619146B2Apr 14, 2020
Non-cytotoxic protein conjugates
IPSEN BIOINNOVATION LTD1 citations73
US9474807B2Oct 25, 2016
Non-cytotoxic protein conjugates
IPSEN BIOINNOVATION LTD4 citations73
US10113159B2Oct 30, 2018
Suppression of cancer
IPSEN BIOINNOVATION LTD2 citations67
US11248219B2Feb 15, 2022
Fusion proteins comprising a non-cytotoxic protease, a translocation domain, and a targeting moiety that binds a galanin receptor and methods for treating, preventing or ameliorating pain using such fusion proteins
IPSEN BIOINNOVATION LTD0 citations48
US10550377B2Feb 4, 2020
Suppression of prostate cancer using a targeted clostridial neurotoxin
IPSEN BIOINNOVATION LTD0 citations46